Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  spirogermanium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 29 for your search:
Start Over
Phase II Chemotherapy with Spirogermanium for Advanced Gynecologic Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: UMCC-8036
Phase II Master Protocol to Evaluate Chemotherapeutic Agents or Combinations for Refractory Malignant Glioma --- SPG
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1382
Phase II Chemotherapy with Spirogermanium for Advanced Stage III/IV Adenocarcinoma of the Breast
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PB-181, WCCC-CO-8012
Phase II Master Protocol Chemotherapy with New Single Agents in Patients with Stage II/III non-Small Cell Carcinoma of the Lung --- Spirogermanium
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-81L3, NCI-T83-0925D, T83-0925
Phase II Chemotherapy with Spirogermanium in Metastatic Lung Cancer of All Histologies
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DM-8287, NCI-C83-0419
Phase II Chemotherapy with Spirogermanium for Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8240
Phase II Chemotherapy with Spirogermanium for Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8218
Phase II Chemotherapy with Spirogermanium for Metastatic Gastric, Colorectal, and Miscellaneous Gastrointestinal Malignant Neoplasms
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8173, NCI-C83-0555
Phase II Master Protocol Chemotherapy for Metastatic or Recurrent Gastric Cancer --- VP-16 vs DHAD (Summary Last Modified 06/97).
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5282
Phase II Master Protocol Chemotherapy with New Agents for Metastatic or Recurrent Colorectal Cancer --- ATDA vs ICRF-187 vs SPG and CHIP vs CBDCA
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4282
Phase II Sequential Chemotherapy with High-Dose ARA-C and SPG for Refractory or Relapsed Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor:
Protocol IDs: MDA-DM-8247, NCI-C82-1308
Phase II Chemotherapy with Spirogermanium for Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DM-8259, NCI-C82-1315
Phase II Chemotherapy with Spirogermanium for Previously Treated Adenocarcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8217
Phase II Chemotherapy with SPG for Refractory Grade III/IV Central Nervous System Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8239
Phase II Chemotherapy with Spirogermanium for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UMCC-8005
Phase II Evaluation of Spirogermanium as a Continuous Infusion for Recurrent or Metastatic, Refractory Ovarian Carcinoma in Adults
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DM-8207
Phase II Chemotherapy with Spirogermanium for Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: MDA-DM-8220
Phase II Chemotherapy with Spirogermanium for Unresectable, Recurrent, or Metastatic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 76
Sponsor: NCI
Protocol IDs: CLB-8075
Phase II Chemotherapy with Spirogermanium for Recurrent or Refractory Adenocarcinoma of the Breast
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-8076
Phase II Chemotherapy with Spirogermanium for Advanced, Inoperable Renal Cell Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-8172
Phase II Master Protocol for Single-Agent Chemotherapy for Refractory Small Cell Bronchogenic Carcinoma --- Spirogermanium vs N-Methylformamide
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4583
Phase II Master Protocol for Single-Agent Chemotherapy for Advanced non-Small Cell Lung Cancer --- 4-Demethoxydaunorubicin
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3583
Phase II Chemotherapy with Spirogermanium in Patients with Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NWBCC-H-0382, NCI-T83-1029D
Start Over